WRM
ELI

Westport Resources Management’s ELITE PHARMACEUTICAL ELI Stock Holding History

Westport Resources Management’s Portfolio ELI Stock Details ELI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,500
Closed -$1K – 902
2015
Q4 		$1K Hold
2,500
– – ﹤0.01% 878
2015
Q3 		$1K Hold
2,500
– – ﹤0.01% 909
2015
Q2 		$1K Hold
2,500
– – ﹤0.01% 908
2015
Q1 		$1K Buy
+2,500
New +$1K ﹤0.01% 981

Other funds holding ELI

GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.26B AUM 31.39% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return
PCA
Personal Capital Advisors Redwood City, California $20.6B AUM 13.65% 1-Year Est. Return

Westport Resources Management's ELI Position: Q1 2016 in Review

Westport Resources Management sold out of ELITE PHARMACEUTICAL (ELI) in Q1 2016, closing a stake of 2,500 shares — an estimated $1K sold.

Westport Resources Management first reported a position in ELI in Q1 2015 and held it in 4 quarters. The position peaked at $1K in Q4 2015. 4 funds tracked by Wall St. Rank hold ELI as of Q1 2016.

  • Westport Resources Management reported no remaining ELITE PHARMACEUTICAL position as of Q1 2016 after selling out during the quarter.
  • Westport Resources Management sold 2,500 ELITE PHARMACEUTICAL shares in Q1 2016, an estimated $1K.
  • Westport Resources Management first reported a position in ELITE PHARMACEUTICAL in Q1 2015 and held it in 4 quarters.
  • Westport Resources Management's ELITE PHARMACEUTICAL position peaked at $1K in Q4 2015.
  • 4 funds tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q1 2016.

Based on Westport Resources Management's 13F filing for Q1 2016, filed 16 May 2016.